Opioid‐induced or pain relief‐reduced symptoms in advanced cancer patients?

[1]  S. Kaasa,et al.  Immediate- or sustained-release morphine for dose finding during start of morphine to cancer patients: a randomized, double-blind trial , 2003, Pain.

[2]  B. Kasimis,et al.  Longitudinal documentation of cancer pain management outcomes: a pilot study at a VA medical center. , 2002, Journal of pain and symptom management.

[3]  G. Pasternak,et al.  Strategies to manage the adverse effects of oral morphine: an evidence-based report. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  S. Mercadante,et al.  Opioid poorly-responsive cancer pain. Part 1: clinical considerations. , 2001, Journal of pain and symptom management.

[5]  P. Manfredi,et al.  Outcome of cancer pain consultations , 2000, Cancer.

[6]  S. Kaasa,et al.  Pain intensity and side effects during titration of morphine to cancer patients using a fixed schedule dose escalation. , 2000, Acta anaesthesiologica Scandinavica.

[7]  S. Kaasa,et al.  Effects on cancer patients' health-related quality of life after the start of morphine therapy. , 2000, Journal of pain and symptom management.

[8]  S. Mercadante.  Pain treatment and outcomes for patients with advanced cancer who receive follow‐up care at home , 1999, Cancer.

[9]  G. Dardanoni,et al.  Monitoring of opioid therapy in advanced cancer pain patients. , 1997, Journal of pain and symptom management.

[10]  W. Korte,et al.  Day-to-day titration to initiate transdermal fentanyl in patients with cancer pain: short- and long-term experiences in a prospective study of 39 patients. , 1996, Journal of pain and symptom management.

[11]  L. Radbruch,et al.  Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service , 1996, Pain.

[12]  S. Grond,et al.  Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1635 cancer patients referred to a pain clinic. , 1994, Journal of pain and symptom management.

[13]  R. Portenoy,et al.  The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions , 1990, Pain.

[14]  E. Bruera,et al.  The cognitive effects of the administration of narcotic analgesics in patients with cancer pain , 1989, Pain.